Your browser is no longer supported. Please, upgrade your browser.
Settings
BAX Baxter International Inc. daily Stock Chart
BAX [NYSE]
Baxter International Inc.
IndexS&P 500 P/E33.28 EPS (ttm)2.61 Insider Own0.20% Shs Outstand510.00M Perf Week1.16%
Market Cap44.35B Forward P/E23.08 EPS next Y3.77 Insider Trans-83.24% Shs Float509.92M Perf Month4.68%
Income1.39B PEG3.10 EPS next Q0.84 Inst Own86.90% Short Float0.99% Perf Quarter14.46%
Sales11.08B P/S4.00 EPS this Y10.50% Inst Trans-1.19% Short Ratio2.18 Perf Half Y18.44%
Book/sh15.32 P/B5.68 EPS next Y11.31% ROA9.50% Target Price92.25 Perf Year22.06%
Cash/sh5.74 P/C15.16 EPS next 5Y10.73% ROE19.50% 52W Range61.05 - 88.28 Perf YTD32.13%
Dividend0.88 P/FCF60.59 EPS past 5Y35.30% ROI12.00% 52W High-1.48% Beta1.02
Dividend %1.01% Quick Ratio2.10 Sales past 5Y3.40% Gross Margin42.70% 52W Low42.46% ATR1.74
Employees50000 Current Ratio2.80 Sales Q/Q-0.10% Oper. Margin13.60% RSI (14)59.66 Volatility1.96% 2.04%
OptionableYes Debt/Eq0.66 EPS Q/Q5.40% Profit Margin14.30% Rel Volume0.68 Prev Close85.78
ShortableYes LT Debt/Eq0.66 EarningsJul 25 BMO Payout26.10% Avg Volume2.31M Price86.97
Recom2.10 SMA202.59% SMA505.56% SMA20016.80% Volume1,573,494 Change1.39%
Jun-26-19Initiated KeyBanc Capital Markets Sector Weight
Apr-08-19Downgrade Evercore ISI Outperform → In-line
Jan-02-19Upgrade Morgan Stanley Underweight → Overweight
Jan-02-19Upgrade Citigroup Neutral → Buy
Nov-02-18Upgrade Argus Hold → Buy
Oct-16-18Initiated Barclays Underweight $73
May-17-18Resumed Piper Jaffray Overweight $77
Feb-06-18Reiterated Citigroup Neutral $66 → $70
Jan-03-18Upgrade Raymond James Mkt Perform → Outperform
Jan-03-18Initiated Evercore ISI Outperform
Jan-02-18Upgrade JP Morgan Neutral → Overweight
Jan-02-18Upgrade BofA/Merrill Neutral → Buy
Aug-17-17Initiated Citigroup Neutral $63
Jul-28-17Reiterated UBS Neutral $57 → $62
Jul-27-17Reiterated Barclays Overweight $64 → $70
Jun-30-17Initiated Cantor Fitzgerald Overweight $70
Apr-27-17Reiterated RBC Capital Mkts Sector Perform $55 → $58
Apr-04-17Upgrade Leerink Partners Mkt Perform → Outperform
Oct-26-16Reiterated RBC Capital Mkts Sector Perform $50 → $55
Oct-13-16Initiated Wells Fargo Outperform
Aug-16-19 09:52AM  Here's Why You Should Hold Onto Omnicell (OMCL) Stock for Now Zacks
09:51AM  QIAGEN Posts QIAstat-Dx Gastrointestinal Panel Study Results Zacks
09:49AM  Here's Why You Should Snap Up Baxter International (BAX) Now Zacks
09:47AM  Accuray (ARAY) Reports Loss in Q4, Revenues Beat Estimates Zacks
09:18AM  The Zacks Analyst Blog Highlights: Deere, Baxter, EPAM Systems, NiSource and Universal Display Zacks
Aug-15-19 02:16PM  Top Analyst Reports: Deere, Baxter & More Zacks
09:13AM  Baxter's PrisMax Adopted by Hamilton Health Care System Zacks
08:34AM  Baxter and COSMED Announce Partnership to Bring Next-generation Indirect Calorimetry Device, Q-NRG+, to Support Clinical Nutrition Globally Business Wire
Aug-14-19 04:15PM  Baxter to Present at the Morgan Stanley 17th Annual Global Healthcare Conference Business Wire
12:14PM  CVS Health Banks on Health Care Benefit Prospects Amid Woes Zacks
09:40AM  ResMed (RMD) Hits a New 52-Week High: What's Driving It? Zacks
09:35AM  Here's Why You Should Hold Onto Insulet (PODD) Stock for Now Zacks
09:33AM  Myriad Genetics (MYGN) Q4 Earnings Lag Estimates, Revenues Up Zacks
08:38AM  Zacks.com featured highlights include: Abbott Laboratories, Baxter International, First Horizon National, OUTFRONT Media and ICF International Zacks
08:15AM  3 Healthcare Stocks at All-Time Highs: Are They Buys? Motley Fool
Aug-13-19 04:15PM  Baxter to Present at the 2019 Wells Fargo Healthcare Conference Business Wire
10:18AM  Boston Scientific Rides on New Products Amid Dull Pacer Sales Zacks
09:35AM  Baxter (BAX) Hits 52-Week High, Can the Run Continue? Zacks
09:10AM  Canopy Growth Set to Acquire Beckley Canopy Therapeutics Zacks
08:07AM  Georgia-based Hamilton Health Care System First in U.S. to Use New Baxter Technology in the ICU Business Wire
07:05AM  5 Stocks Trading Near 52-Week High With More Room to Run Zacks
Aug-12-19 07:40AM  Glaukos (GKOS) Q2 Loss Wider Than Estimates, '19 View Raised Zacks
Aug-09-19 09:45AM  Nevro (NVRO) Q2 Loss Wider Than Expected, Revenues Down Y/Y Zacks
09:33AM  Inogen (INGN) Q2 Earnings Miss Estimates, 2019 View Lowered Zacks
08:54AM  Pacific Biosciences (PACB) Beats on Q2 Earnings & Revenues Zacks
08:37AM  Allscripts (MDRX) Q2 Earnings Top Estimates, Revenues Lag Zacks
07:31AM  Tandem (TNDM) Q2 Loss Narrower Than Expected, Sales Top Mark Zacks
Aug-08-19 10:03AM  BioScrip Closes Option Care Merger, Incurs Wider Q2 Loss Zacks
09:11AM  Cardinal Health (CAH) Q4 Earnings and Revenues Top Estimates Zacks
09:10AM  LHC Group (LHCG) Q2 Earnings Beat Estimates, Revenues Miss Zacks
09:02AM  Orthofix Medical (OFIX) Beats on Q2 Earnings, Margins Down Zacks
08:59AM  OPKO Health (OPK) Q2 Earnings and Revenues Beat Estimates Zacks
08:22AM  Wright Medical (WMGI) Earnings Beat in Q2, Guidance Slashed Zacks
08:10AM  Cardiovascular Systems (CSII) Earnings Match Estimates in Q4 Zacks
Aug-07-19 11:00AM  CVS Health (CVS) Beats on Q2 Earnings, Raises '19 Guidance Zacks
09:10AM  Avanos (AVNS) Q2 Earnings Beat Estimates, Revenues Miss Zacks
08:51AM  AMN Healthcare (AMN) Q2 Earnings and Revenues Top Estimates Zacks
07:49AM  Syneos Health (SYNH) Q2 Earnings Beat Estimates, '19 View Up Zacks
Aug-06-19 11:54AM  Insulet (PODD) Misses on Q2 Earnings, Ups '19 Revenue View Zacks
09:39AM  STERIS (STE) Q1 Earnings Surpass Estimates, Margins Rise Zacks
08:58AM  Henry Schein (HSIC) Q2 Earnings Beat Estimates, Revenues Miss Zacks
08:25AM  Becton, Dickinson (BDX) Beats on Q3 Earnings and Revenues Zacks
Aug-05-19 12:09PM  Baxter International (NYSE:BAX) Seems To Use Debt Rather Sparingly Simply Wall St.
10:30AM  Hill-Rom (HRC) Beats on Q3 Earnings, Tightens '19 Guidance Zacks
10:08AM  Integer Holdings (ITGR) Q2 Earnings Beat, Revenues Miss Zacks
10:06AM  HMS Holdings (HMSY) Q2 Earnings and Revenues Top Estimates Zacks
09:08AM  Intersect (XENT) Q2 Loss Wider Than Estimates, Revenues Miss Zacks
08:25AM  PRA Health (PRAH) Q2 Earnings Beat, EPS Guidance Narrowed Zacks
Aug-02-19 02:58PM  Teleflex (TFX) Q2 Earnings Top Estimates, Margins Improve Zacks
11:38AM  Globus Medical (GMED) Q2 Earnings In Line, Revenue View Up Zacks
11:35AM  Genomic Health (GHDX) to Join Exact Sciences, Posts Q2 Results Zacks
09:27AM  DexCom (DXCM) Q2 Earnings and Revenues Surpass Estimates Zacks
09:15AM  Bio-Rad (Bio) Q2 Earnings Beat Estimates, Margins Expand Zacks
08:34AM  DENTSPLY SIRONA (XRAY) Q2 Earnings Beat, Revenues Fall Y/Y Zacks
08:22AM  DaVita (DVA) Earnings Beat, Revenues Miss Estimates in Q2 Zacks
08:05AM  Bruker (BRKR) Q2 Earnings Beat Estimates, Margins Expand Zacks
Aug-01-19 03:47PM  6 Low Price-Sales Stocks GuruFocus.com
11:51AM  Amedisys (AMED) Q2 Earnings Top Estimates, Margins Decline Zacks
11:49AM  Hologic (HOLX) Beats on Q3 Earnings, Ups '19 Revenue View Zacks
10:46AM  McKesson (MCK) Q1 Earnings and Revenues Surpass Estimates Zacks
10:45AM  AmerisourceBergen (ABC) Q3 Earnings & Revenues Top Estimates Zacks
10:42AM  Luminex (LMNX) Reports Q2 Loss, Beats Revenue Estimates Zacks
10:41AM  CONMED (CNMD) Q2 Earnings and Revenues Surpass Estimates Zacks
09:39AM  ABIOMED (ABMD) Q1 Earnings Top Estimates, Sales Rise in Japan Zacks
09:27AM  IDEXX (IDXX) Beats Q2 Earnings Estimates, Lifts EPS Guidance Zacks
09:23AM  Surmodics (SRDX) Q3 Earnings Beat Estimates, Guidance Raised Zacks
08:24AM  Masimo (MASI) Earnings and Revenues Beat Estimates in Q2 Zacks
Jul-31-19 09:10AM  Fresenius Medical (FMS) Q2 Earnings Miss Estimates, Down Y/Y Zacks
09:08AM  NuVasive (NUVA) Earnings and Revenues Beat Estimates in Q2 Zacks
08:51AM  QIAGEN (QGEN) Misses Q2 Earnings Estimates, Lowers View Zacks
04:33AM  Edited Transcript of BAX earnings conference call or presentation 25-Jul-19 12:30pm GMT Thomson Reuters StreetEvents
Jul-30-19 11:13AM  Congress seeks briefing on potential threat to U.S. heparin supply Reuters
09:54AM  PerkinElmer (PKI) Q2 Earnings and Revenues Miss Estimates Zacks
09:52AM  Ecolab (ECL) Q2 Earnings Surpass Estimates, Revenues Miss Zacks
09:20AM  Baxter Recognized With Highest Achievement on 2019 Diversity Best Practices Inclusion Index Business Wire
08:00AM  Baxter Supports Add-on Payment in Proposed ESRD Payment Rule to Spur Innovation for Dialysis Patients Business Wire
Jul-29-19 04:30PM  Baxter Launches PrisMax in U.S. to Maximize Care for Critically Ill Patients Business Wire
09:18AM  Baxter Adds Finomel With Fish Oil to Ready-to-use Parenteral Nutrition Portfolio Business Wire
Jul-26-19 09:00AM  Baxter (BAX) Moves to Buy: Rationale Behind the Upgrade Zacks
Jul-25-19 07:23PM  Baxter International Inc (BAX) Q2 2019 Earnings Call Transcript Motley Fool
03:21PM  Baxter Boosts Its Full-Year Outlook After Topping Q2 Estimates Motley Fool
09:51AM  Baxter (BAX) Beats on Q2 Earnings & Revenues, Ups EPS View Zacks
08:35AM  Baxter International (BAX) Beats Q2 Earnings and Revenue Estimates Zacks
07:15AM  Baxter Reports Second-Quarter 2019 Results Business Wire
Jul-24-19 10:16AM  Medical Products' Earnings Roster for Jul 25: SYK, BAX & More Zacks
Jul-22-19 09:07AM  Baxter (BAX) to Report Q2 Earnings: What's in the Offing? Zacks
09:04AM  Baxter Announces U.S. FDA Approval of Myxredlin, The First and Only Ready-To-Use Insulin for IV Infusion Business Wire
Jul-19-19 03:07PM  Why Baxter International Inc. (NYSE:BAX) Is A Dividend Rockstar Simply Wall St.
Jul-18-19 10:32AM  Baxter International (BAX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Jul-16-19 08:00AM  Baxter Declares Quarterly Dividend Business Wire
Jul-12-19 10:28AM  The Zacks Analyst Blog Highlights: DaVita, Fresenius, Baxter, Amgen and CVS Zacks
Jul-11-19 09:20AM  Trump's Order on Kidney Care Lifts These Dialysis Stocks Zacks
Jul-10-19 05:31PM  Baxter Supports Advancing American Kidney Health Initiative and Plans Significant U.S. Investment to Help Drive Implementation Business Wire
Jul-03-19 11:05AM  Is It Time To Consider Buying Baxter International Inc. (NYSE:BAX)? Simply Wall St.
Jun-27-19 09:44AM  Patterson Companies' (PDCO) Earnings Miss Estimates in Q4 Zacks
08:30AM  Baxter Highlights Progress Toward Its 2020 Corporate Responsibility Goals and Efforts to Make a Meaningful Difference Around the World Business Wire
Jun-26-19 03:41PM  Baxter Investors 'Know What They're Getting,' KeyBanc Says Benzinga
09:34AM  Baxter International Inc. -- Moody's announces completion of a periodic review of ratings of Baxter International Inc. Moody's
Jun-21-19 01:13PM  Top Analyst Reports for ExxonMobil, Oracle & ADP Zacks
11:05AM  No, The China Trade War Isn't Coming For Your Medicine Here's Why Investor's Business Daily
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kunzler JacquelineSVP, Chief Quality OfficerJun 19Sale80.4659347,7139,023Jun 20 04:01 PM
FORSYTH JOHN DDirectorJun 13Option Exercise24.271,32032,03632,779Jun 14 04:02 PM
FORSYTH JOHN DDirectorJun 13Sale78.211,320103,23731,459Jun 14 04:02 PM
Third Point LLCDirectorMay 16Sale76.375,000,000381,850,00023,008,125May 17 05:08 PM
STALLKAMP THOMAS TDirectorMay 01Sale76.201,00076,2004,737May 03 04:09 PM
STROUCKEN ALBERT P LDirectorApr 01Option Exercise26.785,680152,11032,965Apr 03 05:33 PM
HELLMAN PETER SDirectorApr 01Option Exercise26.785,680152,11028,774Apr 03 05:30 PM
STROUCKEN ALBERT P LDirectorApr 01Sale81.895,680465,13527,285Apr 03 05:33 PM
STALLKAMP THOMAS TDirectorApr 01Sale82.071,04385,5995,737Apr 03 05:31 PM
HELLMAN PETER SDirectorApr 01Sale81.895,680465,13523,094Apr 03 05:30 PM
Pleau ScottSVP, OperationsMar 29Option Exercise50.779,710492,97729,786Apr 02 04:05 PM
Pleau ScottSVP, OperationsMar 29Sale80.009,710776,80020,076Apr 02 04:05 PM
Accogli GiuseppeSVP, President, Global Bus.Mar 18Option Exercise40.2438,2971,541,19996,963Mar 20 04:59 PM
Accogli GiuseppeSVP, President, Global Bus.Mar 18Sale76.7838,2972,940,44458,666Mar 20 04:59 PM
FORSYTH JOHN DDirectorMar 13Option Exercise24.271,50036,40531,703Mar 15 04:24 PM
FORSYTH JOHN DDirectorMar 13Sale75.921,500113,88030,203Mar 15 04:24 PM
STALLKAMP THOMAS TDirectorMar 01Sale75.161,00075,1606,780Mar 04 05:07 PM
STALLKAMP THOMAS TDirectorJan 18Sale70.003,187223,0909,418Jan 23 05:36 PM
FORSYTH JOHN DDirectorDec 13Option Exercise24.271,50036,40531,640Dec 17 04:18 PM
Shapazian Carole JDirectorDec 13Option Exercise39.834,110163,70113,958Dec 17 04:21 PM
Shapazian Carole JDirectorDec 13Sale66.694,110274,0969,848Dec 17 04:21 PM
FORSYTH JOHN DDirectorDec 13Sale67.021,500100,53030,140Dec 17 04:18 PM
Shapazian Carole JDirectorDec 03Option Exercise41.2311,749484,40821,597Dec 06 05:17 PM
Shapazian Carole JDirectorDec 03Sale68.4811,749804,5729,848Dec 06 05:17 PM
Third Point LLCDirectorDec 03Sale68.628,000,000548,960,00028,008,125Dec 04 05:12 PM
Eyre Brik VSVP, President, AmericasSep 17Option Exercise38.1871,6432,735,345137,005Sep 19 05:43 PM
Accogli GiuseppeSVP, President, Global Bus.Sep 17Option Exercise42.5617,647751,13867,785Sep 19 05:42 PM
Eyre Brik VSVP, President, AmericasSep 17Sale77.3178,0126,031,10858,993Sep 19 05:43 PM
Accogli GiuseppeSVP, President, Global Bus.Sep 17Sale77.2717,6471,363,58450,138Sep 19 05:42 PM